Wedbush analyst Daniel Ives maintains Salesforce (NYSE:CRM) with a Outperform and lowers the price target from $215 to $200.
Goldman Sachs Maintains Neutral on Eastman Chemical, Raises Price Target to $89
Goldman Sachs analyst Duffy Fischer maintains Eastman Chemical (NYSE:EMN) with a Neutral and raises the price target from $78 to $89.